Similar Articles
911 Increased ATG5-ATG12 in hepatitis B virus-associated hepatocellular carcinoma and their role in apoptosis
912 Development of a prognostic scoring system for resectable hepatocellular carcinoma
913 Molecular pathological epidemiology in diabetes mellitus and risk of hepatocellular carcinoma
914 Inhibition of apoptosis by oncogenic hepatitis B virus X protein: Implications for the treatment of hepatocellular carcinoma
915 Aberrant regulation of Wnt signaling in hepatocellular carcinoma
916 Pretreatment AKR1B10 expression predicts the risk of hepatocellular carcinoma development after hepatitis C virus eradication
917 Supportive therapies for prevention of hepatocellular carcinoma recurrence and preservation of liver function
918 Technical advances in external radiotherapy for hepatocellular carcinoma
919 Gadoxetic acid-enhanced magnetic resonance imaging for the detection of small hepatocellular carcinoma (≤ 2.0 cm) in patients with chronic liver disease: A meta-analysis
920 Adjuvant sorafenib in hepatocellular carcinoma: A cautionary comment of STORM trial
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA